CHICAGO, Ill. – Gilbane Building Company has commenced construction on the new pharmaceutical manufacturing site expansion for Fresenius Kabi in Melrose Park, Illinois. The scope of work includes construction of a new $250-million, state-of-the-art manufacturing campus for generic sterile injectable pharmaceuticals. The expansion will feature fully automated aseptic filling lines using state-of-the-art isolator technology, expanded lyophilization (freeze-drying) capabilities, formulation areas, a dedicated warehouse for raw materials and components and an administration building with conference center, laboratories, office space and a cafeteria. This complex manufacturing facility will be completed utilizing a fast-track, phased design and phased procurement approach to achieve the … Read more